This webinar briefly introduces the technology behind metabolic phenotyping using global Precision Metabolomics™. Dr. Kirk Pappan will also discuss recent examples of research in type 2 diabetes, a common metabolic disease, which is being aided by metabolomics in discovery-focused and clinical settings.

Presented by:
Kirk Pappan, PhD
Associate Director, Scientific Discovery & Application, Metabolon